Monte Rosa Therapeutics, Inc.
← Back to GLUE Overview

Monte Rosa Therapeutics, Inc. (GLUE)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-5.57

Financial Fundamentals

GLUEQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2020-03-31-26.76
2020-06-30-21.46
2020-09-30-17.55
2020-12-31-5.86
2021-03-31-18.35
2021-06-30-14.18
2021-09-30-12.91
2021-12-31-10.02
2022-03-31-6.82
2022-06-30-4.26
2022-09-30-3.49
2022-12-31-3.02
2023-03-31-3.00
2023-06-30-2.41
2023-09-30-1.71
2023-12-31-2.42
2024-03-31-3.36
2024-06-30-2.31
2024-09-30-4.55
2024-12-317.93
2025-03-312.03
2025-06-30-7.54
2025-09-30-5.64
2025-12-31-5.57

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.